Peroxisomal disorders: complementation analysis using beta-oxidation of very long chain fatty acids
- PMID: 2222480
- DOI: 10.1016/s0006-291x(05)80218-9
Peroxisomal disorders: complementation analysis using beta-oxidation of very long chain fatty acids
Abstract
Complementation studies, using fused cell lines from patients with peroxisomal disorders, have shown correction of defective plasmalogen synthesis and phytanic acid oxidation as well as an increase in the number of peroxisomes. At least six complementation groups have been reported. We demonstrate here that complementing cell lines also acquire the ability to oxidize very long chain fatty acids (VLCFA), and that complementation groups defined with this technique are identical to those reported previously when plasmalogen synthesis was used as the criterion for complementation. This VLCFA complementation technique is of particular value in the study of patients in whom defective VLCFA is the only or major enzymatic defect, and we show complementation between cell lines from two patients each with an isolated defect in one of the peroxisomal fatty acid beta-oxidation enzymes.
Similar articles
-
Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.Mol Genet Metab. 1999 Feb;66(2):91-9. doi: 10.1006/mgme.1998.2789. Mol Genet Metab. 1999. PMID: 10068511
-
Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.Biochem J. 1990 Aug 1;269(3):671-7. doi: 10.1042/bj2690671. Biochem J. 1990. PMID: 2117919 Free PMC article.
-
Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation.Biochem Med Metab Biol. 1993 Apr;49(2):228-42. doi: 10.1006/bmmb.1993.1025. Biochem Med Metab Biol. 1993. PMID: 8484962
-
The inborn errors of peroxisomal beta-oxidation: a review.J Inherit Metab Dis. 1990;13(1):4-36. doi: 10.1007/BF01799330. J Inherit Metab Dis. 1990. PMID: 2109148 Review.
-
[Peroxisomal beta-oxidation].Verh K Acad Geneeskd Belg. 1993;55(1):45-78. Verh K Acad Geneeskd Belg. 1993. PMID: 8480447 Review. Dutch.
Cited by
-
Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.Hum Genet. 1992 Mar;88(5):491-9. doi: 10.1007/BF00219334. Hum Genet. 1992. PMID: 1372585
-
Resistance to erucic acid as a selectable marker for peroxisomal activity: isolation of revertants of an infantile Refsum disease cell line.J Inherit Metab Dis. 1994;17(1):41-59. doi: 10.1007/BF00735394. J Inherit Metab Dis. 1994. PMID: 7519689
-
Bifunctional enzyme deficiency: identification of a new type of peroxisomal disorder in a patient with an impairment in peroxisomal beta-oxidation of unknown aetiology by means of complementation analysis.J Inherit Metab Dis. 1992;15(3):385-8. doi: 10.1007/BF02435983. J Inherit Metab Dis. 1992. PMID: 1357231 No abstract available.
-
Disorders of peroxisome biogenesis: complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency).J Inherit Metab Dis. 1999 May;22(3):314-8. doi: 10.1023/a:1005504104541. J Inherit Metab Dis. 1999. PMID: 10384395 No abstract available.
-
Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.J Clin Invest. 1991 Dec;88(6):1873-9. doi: 10.1172/JCI115509. J Clin Invest. 1991. PMID: 1752949 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources